Valiltramiprosate (C007B-432648)

ALZ-801 is a potent and orally available small-molecule β-amyloid (Aβ) anti-oligomer and aggregation inhibitor, valine-conjugated proagent of Tramiprosate with substantially improved PK properties and gastrointestinal tolerability compared with the parent compound ALZ-801 is an advanced and markedly improved candidate for the treatment of alzheimer’s disease .In VivoALZ-801 (oral administration; 172?mg/kg; single dose) exhibits mean AUCt values of 58,758 and? 5841 ng/ml.h in plasma and brain, respectively. The ALZ-801: Tramiprosate ratio in plasma and brain is 1.8 and 3.1, respectively in male CD-1 mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:β-amyloid. Specification: 0.98 Molecular Formula: C8H18N2O4S Molecular Weight: 238.3 PubChem CID: 25008296 Isomeric SMILES: CC(C)[C@@H](C(=O)NCCCS(=O)(=O)O)N

UPC:

51171518

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

V648369-50mg

CAS:

1034190-08-3

Product Size:

50mg